Document Detail

Fetal and Neonatal Alloimmune Thrombocytopenia: A Management Algorithm Based on Risk Stratification.
MedLine Citation:
PMID:  22015886     Owner:  NLM     Status:  Publisher    
Fetal and neonatal alloimmune thrombocytopenia constitutes the most common cause of severe thrombocytopenia in fetuses and neonates and of intracranial hemorrhage among term newborns. The cornerstone of therapy involves the use of steroids and intravenous immunoglobulins. Despite the risk of potentially devastating consequences to the fetus, fetal blood sampling has typically been used to document response to therapy. We propose a therapeutic algorithm based on risk stratification with individualized treatment optimization without the use of fetal blood sampling.
Luis D Pacheco; Richard L Berkowitz; Kenneth J Moise; James B Bussel; Janice G McFarland; George R Saade
Related Documents :
20505946 - The significance of fetal maxillary length in the first trimester screening for trisomy...
16882266 - Mid-second trimester measurement of fetal nasal bone length in the japanese population.
3914886 - An evaluation of three ultrasound equations for fetal weight prediction.
19753656 - Gestational sac volume: comparison between sonoavc and vocal measurements at 11 + 0 to ...
19658036 - First trimester maternal concentrations of thrombin-inhibitor complexes and the presenc...
20100726 - Gitelman's syndrome in pregnancy: case report and review of the literature.
Publication Detail:
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  118     ISSN:  1873-233X     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1157-1163     Citation Subset:  -    
From the Divisions of Maternal Fetal Medicine and Surgical Critical Care, Departments of Obstetrics & Gynecology and Anesthesiology, The University of Texas Medical Branch at Galveston; Division of Maternal fetal Medicine, Department of Obstetrics & Gynecology, Columbia University Medical Center; Department of Obstetrics & Gynecology and Reproductive Sciences, University of Texas School of Medicine, Houston, Texas; Department of Obstetrics & Gynecology and Pediatrics, Weill Medical College of Cornell University, New York, New York; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, and Platelet and Neutrophil Immunology Laboratory, BloodCenter of Wisconsin; Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neurodevelopmental outcomes after laser therapy for twin-twin transfusion syndrome: a systematic rev...
Next Document:  Three is a crowd: the new doctor-patient-policymaker relationship.